It’s been a while since I’ve posted here. I’m not a person who knows Dr Bala, but I thought I’d chime in as someone who treats this disease (I have 3 on treatment right now).
I’m a radiation oncologist (MD MPH) and I was blown away by the results. Even though the study design was not perfect, with this kind of disease I cannot imagine it not getting approval due to its low toxicity and potential benefit.
I shared the results with other colleagues (including one an MD PhD) and the response was “wow! I wonder when this will be available to us!”
Any product that can give even a few months of survival is huge in glioblastoma. When word gets out to other physicians they will be asking for this.
Market Data 
Markets 
AI
